Richard J. Pollack

Pollack's $3.4M annual compensation (2023) and >$16M over five years is drawn from an organization funded by membership dues from hospitals — many of which are tax-exempt nonprofits claiming financial hardship and requesting public subsidies.

Executive perks (first-class travel, spousal travel, SERP) are unusual for a trade association and have drawn scrutiny from nonprofit watchdogs.

AHA sued twice to block federal hospital price transparency rules — and lost both times. Subsequent reporting found many member hospitals still non-compliant with disclosure requirements even after losing in court. This is the single most visible public-interest conflict under Pollack's tenure.

The AHA board chairman's hospital was reported to have sued patients more than 8,000 times in a single year. The AHA under Pollack issued no public statement or corrective action, drawing criticism that the organization protects institutional interests over patient welfare.

AHA's flagship claim — that nonprofit hospitals return $10+ in community benefit for every $1 in tax exemption — relies on self-reported Form 990 Schedule H data. Critics (including Senate investigators) note the figures include Medicaid shortfalls and bad debt, which many health policy experts do not consider genuine community benefit.

A Senate report found 12 of 16 large health systems dedicated less than 2% of total revenue to charity care.

Pollack dismissed the Senate report as "totally off base" and "tunnel-visioned research."

AHA spent $29M on federal lobbying in 2024 — roughly 17–18% of annual expenses. For context, the general nonprofit benchmark for administration is ~10% of revenue; AHA's top-10 executive compensation alone represented nearly 10% of revenue and ~13% of member dues collected.

Pollack's career (congressional staffer → association lobbyist → association CEO) is a textbook Washington revolving-door trajectory, giving him deep personal relationships with legislators but raising questions about regulatory capture.

AHA has lobbied for 15+ years to maintain a ban on physician-owned hospitals. Critics argue this protects incumbent hospital monopoly profits rather than patient safety, as studies show physician-owned hospitals often deliver comparable or better outcomes at lower cost.

In 2023, AHA spent $169M against $147M in revenue — a $22M deficit funded from $435M in reserves. This spend-down pattern, combined with rising lobbying expenditure and executive compensation, raises sustainability questions members may not fully appreciate.